1. Home
  2. NXL vs NAII Comparison

NXL vs NAII Comparison

Compare NXL & NAII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXL
  • NAII
  • Stock Information
  • Founded
  • NXL 2010
  • NAII 1980
  • Country
  • NXL United States
  • NAII United States
  • Employees
  • NXL N/A
  • NAII N/A
  • Industry
  • NXL Medical Specialities
  • NAII Medicinal Chemicals and Botanical Products
  • Sector
  • NXL Health Care
  • NAII Health Care
  • Exchange
  • NXL Nasdaq
  • NAII Nasdaq
  • Market Cap
  • NXL 21.0M
  • NAII 21.2M
  • IPO Year
  • NXL 2022
  • NAII 1987
  • Fundamental
  • Price
  • NXL $0.89
  • NAII $3.70
  • Analyst Decision
  • NXL Strong Buy
  • NAII
  • Analyst Count
  • NXL 1
  • NAII 0
  • Target Price
  • NXL $5.00
  • NAII N/A
  • AVG Volume (30 Days)
  • NXL 123.3K
  • NAII 3.1K
  • Earning Date
  • NXL 08-06-2025
  • NAII 09-26-2025
  • Dividend Yield
  • NXL N/A
  • NAII N/A
  • EPS Growth
  • NXL N/A
  • NAII N/A
  • EPS
  • NXL N/A
  • NAII N/A
  • Revenue
  • NXL $174,813.00
  • NAII $125,483,000.00
  • Revenue This Year
  • NXL $79.59
  • NAII N/A
  • Revenue Next Year
  • NXL $334.65
  • NAII N/A
  • P/E Ratio
  • NXL N/A
  • NAII N/A
  • Revenue Growth
  • NXL 16.42
  • NAII 4.39
  • 52 Week Low
  • NXL $0.59
  • NAII $2.57
  • 52 Week High
  • NXL $4.49
  • NAII $6.88
  • Technical
  • Relative Strength Index (RSI)
  • NXL 33.31
  • NAII 60.73
  • Support Level
  • NXL $0.86
  • NAII $3.33
  • Resistance Level
  • NXL $1.10
  • NAII $3.73
  • Average True Range (ATR)
  • NXL 0.09
  • NAII 0.11
  • MACD
  • NXL -0.02
  • NAII 0.00
  • Stochastic Oscillator
  • NXL 7.30
  • NAII 63.89

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

About NAII Natural Alternatives International Inc.

Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.

Share on Social Networks: